Neogen Shares Take a Hit Following FDA Warning on HYCOAT Product Recall#USA#New_York#Securities_Law#FDA_Warning#Neogen_Corp
Neogen Shares Take a Hit Following FDA Warning on HYCOAT Product Recall
Neogen Corporation's stock faced a significant drop after an FDA alert concerning its HYCOAT product, prompting an investor investigation for possible securities violations.
third-news.com
September 30, 2026 at 6:49 PM
Neogen Shares Take a Hit Following FDA Warning on HYCOAT Product Recall#USA#New_York#Securities_Law#FDA_Warning#Neogen_Corp
Neogen's Stock Faces Investigation Following FDA Warning on Recalled Product#United_States#New_York#Neogen_Corporation#securities_claims#FDA_Warning
Neogen's Stock Faces Investigation Following FDA Warning on Recalled Product
Neogen Corporation's stock has experienced a significant decline after the FDA issued a warning regarding the HYCOAT equine product, now under scrutiny for potential securities claims.
third-news.com
October 1, 2026 at 2:54 PM
Neogen's Stock Faces Investigation Following FDA Warning on Recalled Product#United_States#New_York#Neogen_Corporation#securities_claims#FDA_Warning
Investors Face Losses as FDA Warns ImmunityBio over Cancer Treatment Claims#USA#San_Francisco#ImmunityBio#FDA_Warning#Anktiva
Investors Face Losses as FDA Warns ImmunityBio over Cancer Treatment Claims
ImmunityBio has come under fire following a warning from the FDA about misleading claims regarding cancer treatments, triggering a class-action lawsuit from investors.
third-news.com
May 14, 2026 at 6:27 PM
Investors Face Losses as FDA Warns ImmunityBio over Cancer Treatment Claims#USA#San_Francisco#ImmunityBio#FDA_Warning#Anktiva
Investors Encouraged to Join Grace Therapeutics Fraud Investigation Led by Schall Law Firm#United_States#Los_Angeles#Schall_Law_Firm#FDA_Warning#Grace_Therapeutics
Investors Encouraged to Join Grace Therapeutics Fraud Investigation Led by Schall Law Firm
The Schall Law Firm is investigating potential fraud claims against Grace Therapeutics, Inc. after significant stock losses due to FDA issues. Join now.
third-news.com
June 11, 2026 at 4:39 PM
Investors Encouraged to Join Grace Therapeutics Fraud Investigation Led by Schall Law Firm#United_States#Los_Angeles#Schall_Law_Firm#FDA_Warning#Grace_Therapeutics
Investors Alarmed as ImmunityBio Faces Class Action Suit Over Misleading Cancer Treatment Claims#USA#Class_Action#San_Francisco#ImmunityBio#FDA_Warning
Investors Alarmed as ImmunityBio Faces Class Action Suit Over Misleading Cancer Treatment Claims
ImmunityBio is currently embroiled in a securities class action lawsuit following FDA warnings about misleading treatment claims, impacting investors significantly.
third-news.com
May 18, 2026 at 4:32 PM
Investors Alarmed as ImmunityBio Faces Class Action Suit Over Misleading Cancer Treatment Claims#USA#Class_Action#San_Francisco#ImmunityBio#FDA_Warning
ImmunityBio Faces Class Action Lawsuit Amid FDA's Warning of Misleading Cancer Treatment Claims#USA#San_Francisco#ImmunityBio#FDA_Warning#Anktiva
ImmunityBio Faces Class Action Lawsuit Amid FDA's Warning of Misleading Cancer Treatment Claims
ImmunityBio is under scrutiny after a lawsuit was filed due to misleading cancer treatment claims, causing shares to plummet over 21%.
third-news.com
May 11, 2026 at 5:01 PM
ImmunityBio Faces Class Action Lawsuit Amid FDA's Warning of Misleading Cancer Treatment Claims#USA#San_Francisco#ImmunityBio#FDA_Warning#Anktiva
ImmunityBio Faces Legal Action After Stock Plummet Following FDA Warning#United_States#New_Orleans#ImmunityBio#FDA_Warning#stock_decline
ImmunityBio Faces Legal Action After Stock Plummet Following FDA Warning
ImmunityBio's stock has significantly dropped by 21% after an FDA warning regarding misleading advertising, prompting potential legal action.
third-news.com
May 9, 2026 at 2:07 AM
ImmunityBio Faces Legal Action After Stock Plummet Following FDA Warning#United_States#New_Orleans#ImmunityBio#FDA_Warning#stock_decline
ImmunityBio Faces Legal Challenges After FDA Questions Cancer Drug Claims, Shares Suffer Major Drop#None#San_Francisco#ImmunityBio#FDA_Warning#Anktiva
ImmunityBio Faces Legal Challenges After FDA Questions Cancer Drug Claims, Shares Suffer Major Drop
ImmunityBio is now embroiled in a class action lawsuit due to FDA concerns over misleading cancer treatment claims, leading to a significant plunge in share value.
third-news.com
April 28, 2026 at 12:39 AM
ImmunityBio Faces Legal Challenges After FDA Questions Cancer Drug Claims, Shares Suffer Major Drop#None#San_Francisco#ImmunityBio#FDA_Warning#Anktiva
ImmunityBio Faces Securities Class Action After FDA Warning and Stock Crash#United_States#Securities_Class_Action#New_Orleans#ImmunityBio#FDA_Warning
ImmunityBio Faces Securities Class Action After FDA Warning and Stock Crash
ImmunityBio, Inc. suffers a major stock decline after receiving an FDA warning. Investors are now directed to file a securities fraud class action.
third-news.com
April 25, 2026 at 2:06 AM
ImmunityBio Faces Securities Class Action After FDA Warning and Stock Crash#United_States#Securities_Class_Action#New_Orleans#ImmunityBio#FDA_Warning
ImmunityBio Faces Class Action Lawsuit Over Misleading Cancer Claims After FDA Warning#ImmunityBio#FDA_Warning#Anktiva
ImmunityBio Faces Class Action Lawsuit Over Misleading Cancer Claims After FDA Warning
ImmunityBio, Inc. is embroiled in a class action lawsuit following an FDA warning regarding its oncology treatment claims, incurring major financial losses.
third-news.com
April 13, 2026 at 11:42 PM
ImmunityBio Faces Class Action Lawsuit Over Misleading Cancer Claims After FDA Warning#ImmunityBio#FDA_Warning#Anktiva
ImmunityBio Faces Securities Fraud Class Action Following FDA Warning and Significant Stock Drop#United_States#Securities_Fraud#New_Orleans#ImmunityBio#FDA_Warning
ImmunityBio Faces Securities Fraud Class Action Following FDA Warning and Significant Stock Drop
ImmunityBio is embroiled in a securities fraud class action following a serious FDA warning and a 21% decline in stock value. Investors can join the lawsuit.
third-news.com
April 11, 2026 at 2:13 AM
ImmunityBio Faces Securities Fraud Class Action Following FDA Warning and Significant Stock Drop#United_States#Securities_Fraud#New_Orleans#ImmunityBio#FDA_Warning
ImmunityBio Faces Class Action Lawsuit Following FDA Warnings on Cancer Treatment Claims#USA#San_Francisco#ImmunityBio#FDA_Warning#Anktiva
ImmunityBio Faces Class Action Lawsuit Following FDA Warnings on Cancer Treatment Claims
ImmunityBio is under legal scrutiny after the FDA sent a warning about misleading claims on their cancer treatments, resulting in a significant plunge in stock price.
third-news.com
April 7, 2026 at 4:34 PM
ImmunityBio Faces Class Action Lawsuit Following FDA Warnings on Cancer Treatment Claims#USA#San_Francisco#ImmunityBio#FDA_Warning#Anktiva
Investor Alert: Class Action Filed Against ImmunityBio Following FDA Warnings#United_States#New_York#Pomerantz#ImmunityBio#FDA_Warning
Investor Alert: Class Action Filed Against ImmunityBio Following FDA Warnings
Pomerantz Law Firm urges ImmunityBio investors experiencing losses to join a class action lawsuit. Key deadlines are approaching for potential claimants.
third-news.com
April 2, 2026 at 3:13 PM
Investor Alert: Class Action Filed Against ImmunityBio Following FDA Warnings#United_States#New_York#Pomerantz#ImmunityBio#FDA_Warning
Corcept Therapeutics Faces Scrutiny Amid FDA Warning on New Drug Application#United_States#San_Francisco#Corcept_Therapeutics#FDA_Warning#Relacorilant
Corcept Therapeutics Faces Scrutiny Amid FDA Warning on New Drug Application
Corcept Therapeutics is under investigation following FDA warnings regarding its drug application. Shareholder concerns are escalating as stock prices plummet.
third-news.com
February 9, 2026 at 1:20 PM
Corcept Therapeutics Faces Scrutiny Amid FDA Warning on New Drug Application#United_States#San_Francisco#Corcept_Therapeutics#FDA_Warning#Relacorilant
Pomerantz Law Firm Investigates Potential Securities Fraud Involving argenx SE Investors#None#Pomerantz_LLP#FDA_Warning#argenx_SE
Pomerantz Law Firm Investigates Potential Securities Fraud Involving argenx SE Investors
Pomerantz LLP is probing claims for argenx SE investors regarding potential securities fraud following FDA warnings on a drug's severe side effects.
third-news.com
July 22, 2025 at 4:02 PM
Pomerantz Law Firm Investigates Potential Securities Fraud Involving argenx SE Investors#None#Pomerantz_LLP#FDA_Warning#argenx_SE
Pomerantz Law Firm Launches Investigation on ICU Medical, Inc. Investors' Claims#United_States#New_York#Pomerantz_LLP#ICU_Medical#FDA_Warning
Pomerantz Law Firm Launches Investigation on ICU Medical, Inc. Investors' Claims
Pomerantz LLP is investigating investor claims regarding ICU Medical, Inc. after the company faced severe regulatory challenges from the FDA.
third-news.com
May 26, 2025 at 2:14 PM
Pomerantz Law Firm Launches Investigation on ICU Medical, Inc. Investors' Claims#United_States#New_York#Pomerantz_LLP#ICU_Medical#FDA_Warning
Investors Alert: Pomerantz Law Firm Investigates ICU Medical, Inc. Potential Securities Fraud#USA#New_York#Pomerantz_Law#ICU_Medical#FDA_Warning
Investors Alert: Pomerantz Law Firm Investigates ICU Medical, Inc. Potential Securities Fraud
Pomerantz Law Firm is examining claims regarding ICU Medical, Inc. amidst allegations of securities fraud linked to FDA warnings on its products.
third-news.com
May 20, 2025 at 1:48 PM
Investors Alert: Pomerantz Law Firm Investigates ICU Medical, Inc. Potential Securities Fraud#USA#New_York#Pomerantz_Law#ICU_Medical#FDA_Warning
Pomerantz Law Firm Investigates ICU Medical, Inc. Amid FDA Concerns and Investor Claims#United_States#New_York#Pomerantz_LLP#ICU_Medical#FDA_Warning
Pomerantz Law Firm Investigates ICU Medical, Inc. Amid FDA Concerns and Investor Claims
Pomerantz LLP is looking into potential claims against ICU Medical, Inc. following an FDA warning. Investors are being encouraged to take action.
third-news.com
May 12, 2025 at 9:47 PM
Pomerantz Law Firm Investigates ICU Medical, Inc. Amid FDA Concerns and Investor Claims#United_States#New_York#Pomerantz_LLP#ICU_Medical#FDA_Warning
Pomerantz Law Firm Launches Investigation Into ICU Medical Investors' Claims#United_States#New_York#Pomerantz_Law#ICU_Medical#FDA_Warning
Pomerantz Law Firm Launches Investigation Into ICU Medical Investors' Claims
The Pomerantz Law Firm is investigating claims of securities fraud against ICU Medical, following an FDA warning that impacted the company's stock prices significantly.
third-news.com
May 6, 2025 at 6:11 PM
Pomerantz Law Firm Launches Investigation Into ICU Medical Investors' Claims#United_States#New_York#Pomerantz_Law#ICU_Medical#FDA_Warning
Pomerantz Law Firm Investigates ICU Medical for Alleged Securities Fraud Amid FDA Warnings#Pomerantz_LLP#ICU_Medical#FDA_Warning
Pomerantz Law Firm Investigates ICU Medical for Alleged Securities Fraud Amid FDA Warnings
Pomerantz Law Firm is looking into potential securities fraud claims against ICU Medical following FDA safety warnings that affected stock price.
third-news.com
April 28, 2025 at 10:43 PM
Pomerantz Law Firm Investigates ICU Medical for Alleged Securities Fraud Amid FDA Warnings#Pomerantz_LLP#ICU_Medical#FDA_Warning
Schall Law Firm Investigates ICU Medical Investors for Possible Fraud Claims#USA#Los_Angeles#Schall_Law_Firm#ICU_Medical#FDA_Warning
Schall Law Firm Investigates ICU Medical Investors for Possible Fraud Claims
ICU Medical, Inc. shareholders may be eligible to join a fraud investigation led by the Schall Law Firm for alleged security law violations. Learn more.
third-news.com
April 28, 2025 at 1:16 PM
Schall Law Firm Investigates ICU Medical Investors for Possible Fraud Claims#USA#Los_Angeles#Schall_Law_Firm#ICU_Medical#FDA_Warning